This topic contains 0 replies, has 1 voice, and was last updated by  Cystic Fibrosis News Moderator 1 week, 4 days ago.

  • Author
  • #13313

    A single dose of Translate Bio’s first-in-class mRNA therapy MRT5005 may improve lung function in cystic fibrosis, interim Phase 1/2 trial data shows. Click here to read more about it.

    What are your thoughts about this study and its findings?

You must be logged in to reply to this topic.

Copyright © 2017-2019 All rights reserved.

©2019 KLEO Template a premium and multipurpose theme from Seventh Queen